A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers.
Mahalingam D, Owonikoko TK, Delpassand E, Mulcahy MF, Kalyan A, Ulahannan S, Cheung K, Izumi Y, Johansen M, Madden T, Shimoyama S, Subach RA, Suzuki T, Wages DS, Wheeler C, Richardson DL.
Mahalingam D, et al. Among authors: cheung k.
Cancer. 2025 Jan 1;131(1):e35680. doi: 10.1002/cncr.35680.
Cancer. 2025.
PMID: 39748726